Lesson Overview

An Expert’s Experience with a New Feline Anti-NGF Monoclonal Antibody: A Case Study


Nerve growth factor (NGF) has emerged as an important target to control osteoarthritis (OA) pain. One highly effective way to target NGF is through the use of monoclonal antibodies (mAbs), for which there is now an approved and available option for veterinarians. In this webinar, Dr. Tamara Grubb will describe the role of NGF in the pain pathway and share her experience in using the first and only feline anti-NGF mAb therapy. Challenges in identifying and treating chronic pain in cats will also be discussed.

Not looking for CE credit for this course? You can skip entering your information below and proceed to viewing the webinar here.

Syllabus for An Expert’s Experience with a New Feline Anti-NGF Monoclonal Antibody: A Case Study

Reading List

Webinars

Quiz

@quiz_title

@quiz_title

Certificate

1 Credit Hour

Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© 2023 Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Terms & Conditions | DMCA Copyright | Privacy Policy | Acceptable Use Policy